Amanote Research
Register
Sign In
Salpingo-Oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
JAMA - Journal of the American Medical Association
- United States
doi 10.1001/jama.296.2.185
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
July 12, 2006
Authors
Amy Finch
Publisher
American Medical Association (AMA)
Related search
Selected Features of Breast and Peritoneal Cancers Diagnosed in BRCA1 Carriers After Risk-Reducing Salpingo-Oophorectomy
Hereditary Cancer in Clinical Practice
Oncology
Genetics
Uptake and Timing of Bilateral Prophylactic Salpingo-Oophorectomy Among BRCA1 and BRCA2 Mutation Carriers
Genetics in Medicine
Medicine
Genetics
Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of BRCA1 and BRCA2 Mutation Carriers
Breast Cancer Research
Cancer Research
Oncology
Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
Annals of Surgical Oncology
Oncology
Surgery
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
Clinical Cancer Research
Cancer Research
Oncology
Risk-Reducing Salpingo-Oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA Testing
JAMA Internal Medicine
Internal Medicine
International Trends in the Uptake of Cancer Risk Reduction Strategies in Women With a BRCA1 or BRCA2 Mutation
British Journal of Cancer
Cancer Research
Oncology
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
JAMA - Journal of the American Medical Association
Medicine
A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-Resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
